Nexxus Petro (544265)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 26.11% indicates strong capital efficiency.
• P/E of 8.56 and PEG of 0.15 suggest low valuation relative to profit growth of 52.63%.
• Sales growth of 62.07% shows rapid expansion.
• Piotroski F-Score of 7/9 points to generally healthy financials.

Concerns

• Net profit margin is roughly 1.4% on latest quarter sales of ₹141 Cr, leaving little room for cost or price shocks.
• No data on debt/equity, book value, promoter holding, or 52-week range; insufficient for a Graham-style margin of safety.
• Zero dividend yield means no cash income while waiting.
• Petrochemicals are cyclical, so the 62% sales growth may not be sustainable.

AI Analysis

One of the first lessons I learned in Omaha is that a low price-to-earnings multiple can be an illusion. Nexxus Petro trades at ₹83.50, with a market cap of ₹58 Cr and a P/E of 8.56. That looks cheap. But this is a petrochemical business, and today's single-digit P/E may be based on earnings near the top of a commodity cycle. In the latest quarter, sales were ₹141 Cr but net profit was only ₹2 Cr. That is roughly a 1.4% net margin. Such thin margins offer little protection if input costs rise or product prices fall. There is something to admire. ROCE is 26.11%, sales grew 62.07%, profit grew 52.63%, and the Piotroski F-Score of 7/9 suggests decent financial health. A PEG of 0.15 says the market is not paying much for this growth. But I cannot make a Graham-style margin-of-safety calculation without book value, debt-to-equity, promoter holding, or a 52-week trading range. The dividend yield is zero, so I am not getting paid to wait. Petrochemicals reward efficient operators during up-cycles and punish everyone during downturns. The 62% sales growth might be volume, price, or a mix; I need to know which. If the balance sheet is strong and ROCE holds up, this could be a small compounding machine. But based on what I know, I would not call it a wonderful business yet. I would put it on the watch list and wait for more disclosure and a downturn to test its durability.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer